MMP9 and breast carcinoma: Our study reveals a new molecular regulatory mechanism, that is, TIMELESS can inhibit breast cancer migration and invasion by reducing the transcription activity of MMP9, and systematically expounds the molecular mechanism of TIMELESS regulating NF-κB/MMP9 pathway.